tradingkey.logo

Alzamend Neuro Announces Initiation Date Of Phase II Clinical Trial Of AL001 For Treatment Of Bipolar Disorder To Take Place At Massachusetts General Hospital

ReutersMar 4, 2025 2:14 PM

- Alzamend Neuro Inc ALZN.O:

  • ALZAMEND NEURO ANNOUNCES INITIATION DATE OF PHASE II CLINICAL TRIAL OF AL001 FOR TREATMENT OF BIPOLAR DISORDER TO TAKE PLACE AT MASSACHUSETTS GENERAL HOSPITAL

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

Tradingkey
KeyAI